ZYMAXID™ (gatifloxacin ophthalmic solution) 0.5% solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Aerobic Gram-Positive Bacteria

Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus mitis group*
Streptococcus oralis*
Streptococcus pneumoniae

Aerobic Gram-Negative Bacteria

Haemophilus influenzae

*Efficacy for this organism was studied in fewer than 10 infections.

Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7.

Dosage Forms And Strengths

Five (5) mL bottle containing 2.5 mL of a 0.5% sterile topical ophthalmic solution.

Storage And Handling

ZYMAXID™ (gatifloxacin ophthalmic solution) 0.5% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip, and a tan, high impact polystyrene (HIPS) cap in the following sizes:

2.5 mL in 5 mL bottle: NDC 0023-3615-25

Storage

Store at 15°-25°C (59°-77°F). Protect from freezing.

Allergan, Inc. Irvine, CA 92612, U.S.A. Licensed from Kyorin Pharmaceuticals Co., Ltd.

Last reviewed on RxList: 6/23/2010
This monograph has been modified to include the generic and brand name in many instances.